Services Provided
- Articles & white papers
- Dossiers
- Formulary within payors (eg, AMCP)
- Coverage for Medicare & Medicaid
- Formulary kits
- Government regulations, compliance, and accreditation content
- Manuscripts
- Medical policies, including
- Policies to align with Medicare & Medicaid coverage determination
- Posters
- Reprint carriers & leave-behinds
- Slide decks
Samples*
Exa-cel and Lovo-cel Provide Potential Functional Cure for Patients with SCD or TDT
FDA-Approved Nirogacestat Demonstrates Improved Patient Outcomes in Desmoid Tumor Management
FDA Approval of SYFOVRE (Pegcetacoplan) and IZERVAY (Avacincaptad Pegol) Reshapes Management of GA
Nivolumab Improves Response Rate Versus Everolimus in Japanese Renal Cell Carcinoma Patients
RNA biomarker promotes pancreatic cancer progression via mRNA stabilization
Solanezumab Does Not Significantly Reduce Cognitive Decline in Alzheimer Disease
*Due to proprietary nature and regulatory requirements, dossiers, formulary kits, and specific leave-behinds cannot be included within portfolio.
Types of clients include
- Laboratories
- Managed healthcare industry
- Medical policy
- Medical communication
- Pharmaceutical & life science industries
- Other healthcare-focused organizations
Photos by National Cancer Institute (lower) and Scott Graham (upper) on Unsplash
Jerm Day-Storms, PhD, MWC
Contact me: jerm@day-storms.com | (863) 279-7910
Copyright 2025 Day-Storms, LLC